Business Wire

CA-ANDERSEN-GLOBAL

29.6.2022 13:11:10 CEST | Business Wire | Pressemeddelelse

Del
Andersen Global går ind i New Zealand og tilføjer to samarbejdende virksomheder

Andersen Global etablerer skattemæssige og juridiske kompetencer i New Zealand gennem samarbejdsaftaler med to virksomheder beliggende i Auckland – advokatfirmaet Turner Hopkins og skatte- og rådgivningsfirmaet Bellingham Wallace. Virksomhederne opretholder solide forbindelser i regionen og vil spille en central rolle i at drive forretning og levere integrerede, globale løsninger for at skabe langsigtet værdi for kunderne.

Turner Hopkins blev grundlagt i 1923 og har i næsten 100 år leveret fuldservice-kompetencer inden for ejendomsret, selskabs- og erhvervsret, procesførelse, finans, ansættelsesret, familieret, private kunder, ejendoms- og immigrationsret. Turner Hopkins’ tværfaglige team af fagfolk har stor erfaring med at arbejde på tværs af en række brancher og tage sig af kundernes behov med omfattende, skræddersyede løsninger.

”Vi er stolte over vores kundefokuserede tilgang og vores forpligtelse til at sikre, at vi fastholder den højeste kaliber af advokater og fagfolk, hvilket har gjort det muligt for os at opretholde en konkurrencefordel i Auckland-regionen i næsten et århundrede,” siger ledende partner Michael Robinson. ”Samarbejdet med Andersen Global gør os i stand til fortsat at arbejde problemfrit med kunder og levere kvalitetsløsninger til kunder med stigende globale behov”.

Bellingham Wallace blev etableret i 2012 og grundlagt af to ledende partnere Matt Bellingham og Aaron Wallace, for at arbejde tæt sammen med kunder lige fra små til store privatejede virksomheder. Virksomheden tilbyder en række fuldservice-kompetencer inden for rådgivning, ledelse, skat, strategi, due diligence og værdiansættelse for at drive vækst og styre risici for kundernes virksomheder.

”Vores virksomhed har oplevet enestående vækst i løbet af de seneste par år, alt imens vi fortsætter med at prioritere alle vores kunders behov og udvide vores eksisterende kapaciteter på markedet,” siger medgrundlægger og ledende medpartner Matt Bellingham. ”Samarbejdet med Andersen Global viser vores forpligtelse til ekspertise og styrker vores kundefokuserede tilgang, da de yderligere globale ressourcer vil styrke vores evne til at imødekomme kundernes skiftende behov,” tilføjer Aaron Wallace.

Andersen Globals bestyrelsesformand og CEO Mark Vorsatz siger: ”Turner Hopkins og Bellingham Wallace vil være store aktiver i vores bestræbelse på at imødekomme vores voksende behov i regionen. Disse virksomheder deler vores organisations engagement i ledelse og udviser de højeste professionelle standarder, og vi forudser et synergistisk samarbejde mellem vores fagfolk. Det er vigtigt for os at samarbejde med disse virksomheder, mens vi fortsat giver klassens bedste løsninger til vores kunder over hele kloden og styrker vores tilstedeværelse i Asien og Stillehavsområdet.”

Andersen Global er en international sammenslutning af juridisk adskilte, uafhængige medlemsvirksomheder, bestående af skatte- og juraeksperter i hele verden. Andersen Global blev stiftet af den amerikanske medlemsvirksomhed Andersen Tax LLC i 2013, og Andersen Global har nu over 11.000 fagfolk på verdensplan og er repræsenteret på mere end 360 lokaliteter via sine medlemsvirksomheder og samarbejdende virksomheder.

Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye